Nyxoah is trading 5.7% down at $1.33 in pre-market following its second-quarter earnings release. - The company reported strong revenue growth driven by the commercialization of its Genio system in the U.S.. - It posted an operating loss of €20.6 million for the quarter, and reiterated its 2026 guidance.